Sangamo Therapeutics Inc.
SGMOQBiotechnology
$0.12+1.61%As of Oct 29vs prior close
- Market cap
- $49.7M
- P/E (TTM)
- –
- From 52W high
- −80.02%
- EPS (LTM)
- -$0.38
- Revenue (LTM)
- $34.6M
- Net margin
- -356.89%
- Dividend yield
- 0.00%
Nomior Score
16
Distressed LaggardBottom 5% of the scored universe
Growth—
Quality25
Value34
Momentum29
Resilience19
Growth
+8.24%revenue a year over 9 fiscal years
YE16 $19.4MLTM $34.6M
Connections
Revenue to profitQ1 YE26
The operating loss was 2215% of revenue, wider by 1755 pts on a year.